Concepedia

Francesco Berlanda-Scorza

FB

Statistics

Publications

5

Citations

377

H-Index

5

Active since

2017

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Program for Appropriate Technology in Health

University of Cincinnati Medical Center

Clinical Research Institute

Duke University

Francesco Berlanda-Scorza is an author at Icahn School of Medicine at Mount Sinai specializing in viral vaccines, vaccination, and immunology.

Publications per year

2017–2024

5

Publications

5

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

Raffael Nachbagauer, Wen‐Chun Liu, Angela Choi et al. · npj Vaccines · 2017 · 143 citations · Full text

, , +17

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 140 citations · Full text

, , +17

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

Wen‐Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer et al. · Frontiers in Immunology · 2019 · 55 citations · Full text

, , +17

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model

Wen‐Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer et al. · Vaccines · 2021 · 24 citations · Full text

, , +17

A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein

Carly M. Bliss, Raffael Nachbagauer, Chiara Mariottini et al. · EBioMedicine · 2024 · 15 citations · Full text

, , +16

1–5 of 5